Cystatin C is associated with adverse COVID-19 outcomes in diverse populations
Authors:
Open Access
- 31 August 2022
- Vol. 25 (10) , 105040
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Corticosteroids, But Not TNF Antagonists, Are Associated With Adverse COVID-19 Outcomes in Patients With Inflammatory Bowel Diseases: Results From an International RegistryGastroenterology, 2020
- Cytokine release syndrome in severe COVID-19Science, 2020
- An interactive web-based dashboard to track COVID-19 in real timeThe Lancet Infectious Diseases, 2020
- Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort studyThe Lancet, 2020
- Genomic structural equation modelling provides insights into the multivariate genetic architecture of complex traitsNature Human Behaviour, 2019
- Mixed-model association for biobank-scale datasetsNature Genetics, 2018
- Developing and evaluating polygenic risk prediction models for stratified disease preventionNature Reviews Genetics, 2016
- Estimating Glomerular Filtration Rate from Serum Creatinine and Cystatin CNew England Journal of Medicine, 2012
- Overweight, Obesity, and Elevated Serum Cystatin C Levels in Adults in the United StatesThe American Journal of Medicine, 2008
- The role of cystatins in cells of the immune systemFEBS Letters, 2006